Gut–brain axis in the executive function of austism spectrum disorder
Visualitza/
Impacte
Scholar |
Altres documents de l'autoria: Roman, Pablo; Rueda-Ruzafa, Lola; Cardona, Diana; Cortés Rodríguez, Alda Elena
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36084
comunitat-uji-handle3:10234/36085
comunitat-uji-handle4:
INVESTIGACIONMetadades
Títol
Gut–brain axis in the executive function of austism spectrum disorderData de publicació
2018Editor
Lippincott, Williams & WilkinsISSN
0955-8810; 1473-5849Cita bibliogràfica
ROMAN, Pablo, et al. Gut–brain axis in the executive function of austism spectrum disorder. Behavioural Pharmacology, 2018, vol. 29, no 7, p. 654-663Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
https://journals.lww.com/behaviouralpharm/Abstract/2018/10000/Gut_brain_axis_in_ ...Versió
info:eu-repo/semantics/submittedVersionParaules clau / Matèries
Resum
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impaired communication and social interactions, and repetitive behavioural patterns. These patterns are believed to be dysfunctional ... [+]
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impaired communication and social interactions, and repetitive behavioural patterns. These patterns are believed to be dysfunctional symptoms in executive processing, which impact other cognitive functions such as attention or cognitive flexibility. In recent years, several studies have shown that certain intestinal bacteria may play a role in shaping cognitive networks encompassing emotional and social domains. A microbiota–gut–brain axis is known to exist, establishing several mechanisms by which microbiota may modulate brain development, function and behaviour, including immune, endocrine and neural pathways. As the aetiology of ASD is largely unknown, some studies have shown that intestinal bacteria may be involved in its pathogenesis. The aim of this review was to focus on the role of the gut–brain axis in ASD and, specifically, on its role in executive functions. First, we summarize the relationship between the gastrointestinal and cognitive symptoms of ASD patients. In addition, we highlight the evidence that supports and emphasizes the involvement of gut microbiota, and the putative underlying mechanisms in this population. Finally, we present evidence from preclinical and clinical studies on the modulation of microbiota and their effects on cognitive symptoms, specifically in relation to executive function. In conclusion, manipulation of microbiota could be a positive intervention to improve ASD symptoms. However, more research evaluating the role of microbiota in the cognitive symptoms ASD is needed. [-]
Publicat a
Behavioural Pharmacology, 2018, vol. 29, no 7Drets d'accés
Copyright © Wolters Kluwer Health, Inc.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/openAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/openAccess
Apareix a les col.leccions
- INF_Articles [274]